Stem Cells for Reutilization in Bone Regeneration

Journal of Cellular Biochemistry

Volumn 116, Issue 4, 2015, Pages 487-493

  Im, Gun Il ^a  

^a Dongguk University Ilsan Hospital   (South Korea)

Author keywords

BONE DEFECTS; BONE REGENERATION; OSTEONECROSIS OF FEMORAL HEAD; REUTILIZATION; STEM CELLS

Indexed keywords

HYDROXYAPATITE; TELOMERASE;

ADULT STEM CELL; ARTICLE; BONE CONDUCTION; BONE DEFECT; BONE LESION; BONE NECROSIS; BONE REGENERATION; BONE TRANSPLANTATION; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; ENZYME ACTIVITY; FRACTURE HEALING; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PSEUDARTHROSIS; STEM CELL TRANSPLANTATION; SYSTEMIC CIRCULATION; ANIMAL; BONE DISEASES; CLASSIFICATION; PROCEDURES; STEM CELL;

ANIMALS; BONE DISEASES; BONE REGENERATION; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84943532081     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25027     Document Type: Article

References (75)

1. Alessandri G, Pagano S, Bez A, Benetti A, Pozzi S, Iannolo G, Baronio M, Invernici G, Caruso A, Muneretto C, Bisleri G, Parati E,. 2004. Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 364: 1872-1883.
2. Alves H, Munoz-Najar U, de Wit J, Renard AJ, Hoeijmakers JH, Sedivy JM, van Blitterswijk C, de Boer J,. 2009. A link between the accumulation of DNA damage and loss of multi-potency of human mesenchymal stromal cells. J Cell Mol Med 14: 2729-2738.
3. Amini AR, Laurencin CT, Nukavarapu SP,. 2012. Bone tissue engineering: Recent advances and challenges. Crit Rev Biomed Eng 40: 363-408.
4. Arinzeh TL, Peter SJ, Archambault MP, van den Bos C, Gordon S, Kraus K, Smith A, Kadiyala S,. 2003. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 85: 1927-1935.
5. Arvidson K, Abdallah B, Applegate L, Baldini N, Cenni E, Gomez-Barrena E, Granchi D, Kassem M, Konttinen Y, Mustafa K,. 2011. Bone regeneration and stem cells. J Cell Mol Med 15: 718-746.
6. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R,. 2000. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol 28: 707-715.
7. Barry FP, Murphy JM,. 2004. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36: 568-584.
8. Bensaid W, Oudina K, Viateau V, Potier E, Bousson V, Blanchat C, Sedel L, Guillemin G, Petite H,. 2005. De novo reconstruction of functional bone by tissue engineering in the metatarsal sheep model. Tissue Eng 11: 814-824.
9. Both SK, van Apeldoorn AA, Jukes JM, Englund MC, Hyllner J, van Blitterswijk CA, de Boer J,. 2011. Differential bone-forming capacity of osteogenic cells from either embryonic stem cells or bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med 5: 180-190.
10. Bruder SP, Kraus KH, Goldberg VM, Kadiyala S,. 1998. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80: 985-996.
11. Buttery LD, Bourne S, Xynos JD, Wood H, Hughes FJ, Hughes SP, Episkopou V, Polak JM,. 2001. Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng 7: 89-99.
12. Cancedda R, Giannoni P, Mastrogiacomo M,. 2007. A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 28: 4240-4250.
13. Caplan AI,. 1991. Mesenchymal stem cells. J Orthop Res 9: 641-650.
14. Chatterjea A, Meijer G, van Blitterswijk C, de Boer J,. 2010. Clinical application of human mesenchymal stromal cells for bone tissue engineering. Stem Cells Int 2010: 215625.
15. Correia C, Grayson W, Park M, Hutton D, Zhou B, Guo XE, Niklason L, Sousa R, Reis R, Vunjak-Novakovic G. 2011. In vitro model of vascularized bone: Synergizing vascular development and osteogenesis. PLoS One 6:e28352
16. Cowan CM, Aalami OO, Shi YY, Chou YF, Mari C, Thomas R, Quarto N, Nacamuli RP, Contag CH, Wu B, Longaker MT,. 2005. Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover. Tissue Eng 11: 645-658.
17. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP,. 2001. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44: 1928-1942.
18. Fan M, Chen W, Liu W, Du GQ, Jiang SL, Tian WC, Sun L, Li RK, Tian H,. 2010. The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction. Rejuvenation Res 13: 429-438.
19. Gangji V, De Maertelaer V, Hauzeur J-P,. 2011. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: Five year follow-up of a prospective controlled study. Bone 49: 1005-1009.
20. Gangji V, Hauzeur J-P,. 2009. Cellular-based therapy for osteonecrosis. Orthop Clin North Am 40: 213-221.
21. Gangji V, Hauzeur J-P, Schoutens A, Hinsenkamp M, Appelboom T, Egrise D,. 2003. Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J Rheumatol 30: 348-351.
22. Garrison KR, Donell S, Ryder J, Shemilt I, Mugford M, Harvey I, Song F,. 2007. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: A systematic review. Health Technol Assess 11: 1-150, iii-iv.
23. Giannoudis PV, Dinopoulos H, Tsiridis E,. 2005. Bone substitutes: An update. Injury 36 (Suppl 3): S20-S27.
24. Hanada K, Dennis JE, Caplan AI,. 1997. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 12: 1606-1614.
25. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI,. 1992. Characterization of cells with osteogenic potential from human marrow. Bone 13: 81-88.
26. Hernigou P, Beaujean F,. 1997. Abnormalities in the bone marrow of the iliac crest in patients who have osteonecrosis secondary to corticosteroid therapy or alcohol abuse. J Bone Joint Surg 79: 1047-1053.
27. Hernigou P, Beaujean F,. 2002. Treatment of osteonecrosis with autologous bone marrow grafting. Clini Orthop Relat Res 405: 14-23.
28. Hernigou P, Bernaudin F, Reinert P, Kuentz eM, Vernant J,. 1997. Bone-marrow transplantation in sickle-cell disease. Effect on osteonecrosis: A case report with a four-year follow-up. J Bone Joint Surg 79: 1726-1730.
29. Hernigou P, Poignard A, Zilber S, Rouard H,. 2009. Cell therapy of hip osteonecrosis with autologous bone marrow grafting. Indian J Orthop 43: 40.
30. Hibi H, Yamada Y, Ueda M, Endo Y,. 2006. Alveolar cleft osteoplasty using tissue-engineered osteogenic material. Int J Oral Maxillofac Surg 35: 551-555.
31. Hoffman LM, Carpenter MK,. 2005. Characterization and culture of human embryonic stem cells. Nat Biotechnol 23: 699-708.
32. Hwang YS, Polak JM, Mantalaris A,. 2008. In vitro direct osteogenesis of murine embryonic stem cells without embryoid body formation. Stem Cells Dev 17: 963-970.
33. Im GI, Shin YW, Lee KB,. 2005. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells. Osteoarthritis Cartilage 13: 845-853.
34. Jones EA, English A, Kinsey SE, Straszynski L, Emery P, Ponchel F, McGonagle D,. 2006. Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin Cytom 70: 391-399.
35. Kagami H, Agata H, Tojo A,. 2011. Bone marrow stromal cells (bone marrow-derived multipotent mesenchymal stromal cells) for bone tissue engineering: Basic science to clinical translation. Int J Biochem Cell Biol 43: 286-289.
36. Karp JM, Ferreira LS, Khademhosseini A, Kwon AH, Yeh J, Langer RS,. 2006. Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells 24: 835-843.
37. Kawaguchi J, Mee PJ, Smith AG,. 2005. Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors. Bone 36: 758-769.
38. Kawate K, Yajima H, Ohgushi T, Kotobuki N, Sugimoto K, Ohmura T, Kobata Y, Shigematsu K, Kawamura K, tamai K,. 2006. Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: Transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula. Artif Organs 30: 960-962.
39. Ko JY, Park S, Im GI,. 2014. Osteogenesis from human induced pluripotent stem cells: An in vitro and in vivo comparison with mesenchymal stem cells. Stem Cells Dev 23: 1788-1797.
40. Kon E, Muraglia A, Corsi A, Bianco P, Marcacci M, Martin I, Boyde A, Ruspantini I, Chistolini P, Rocca M, Giardino R, Cancedda R, Quarto R,. 2000. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 49: 328-337.
41. Kretlow JD, Mikos AG,. 2007. Review: Mineralization of synthetic polymer scaffolds for bone tissue engineering. Tissue Eng 13: 927-938.
42. Kruyt MC, de Bruijn JD, Wilson CE, Oner FC, van Blitterswijk CA, Verbout AJ, Dhert WJ,. 2003. Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats. Tissue Eng 9: 327-336.
43. Kruyt MC, Dhert WJ, Yuan H, Wilson CE, van Blitterswijk CA, Verbout AJ, de Bruijn JD,. 2004. Bone tissue engineering in a critical size defect compared to ectopic implantations in the goat. J Orthop Res 22: 544-551.
44. Kruyt MC, Wilson CE, de Bruijn JD, van Blitterswijk CA, Oner CF, Verbout AJ, Dhert WJ,. 2006. The effect of cell-based bone tissue engineering in a goat transverse process model. Biomaterials 27: 5099-5106.
45. Law S, Chaudhuri S,. 2013. Mesenchymal stem cell and regenerative medicine: Regeneration versus immunomodulatory challenges. Am J Stem Cells 2: 22-38.
46. Lim YW, Kim YS, Lee JW, Kwon SY,. 2013. Stem cell implantation for osteonecrosis of the femoral head. Ex Mol Med 45: e61.
47. Mankani MH, Kuznetsov SA, Marshall GW, Robey PG,. 2008. Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng Part A 14: 1949-1958.
48. Mankani MH, Kuznetsov SA, Wolfe RM, Marshall GW, Robey PG,. 2006. In vivo bone formation by human bone marrow stromal cells: Reconstruction of the mouse calvarium and mandible. Stem Cells 24: 2140-2149.
49. Mao Q, Jin H, Liao F, Xiao L, Chen D, Tong P,. 2013. The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: A five year follow-up study. Bone 57: 509-516.
50. Mareschi K, Ferrero I, Rustichelli D, Aschero S, Gammaitoni L, Aglietta M, Madon E, Fagioli F,. 2006. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem 97: 744-754.
51. Marolt D, Knezevic M, Novakovic GV,. 2010. Bone tissue engineering with human stem cells. Stem Cell Res Ther 1: 10.
52. Marrony S, Bassilana F, Seuwen K, Keller H,. 2003. Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells. Bone 33: 426-433.
53. Mastrogiacomo M, Corsi A, Francioso E, Di Comite M, Monetti F, Scaglione S, Favia A, Crovace A, Bianco P, Cancedda R,. 2006. Reconstruction of extensive long bone defects in sheep using resorbable bioceramics based on silicon stabilized tricalcium phosphate. Tissue Eng 12: 1261-1273.
54. Mauney JR, Volloch V, Kaplan DL,. 2005. Role of adult mesenchymal stem cells in bone tissue engineering applications: Current status and future prospects. Tissue Eng 11: 787-802.
55. Meijer GJ, de Bruijn JD, Koole R, van Blitterswijk CA,. 2008. Cell based bone tissue engineering in jaw defects. Biomaterials 29: 3053-3061.
56. Mesimaki K, Lindroos B, Tornwall J, Mauno J, Lindqvist C, Kontio R, Miettinen S, Suuronen R,. 2009. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. Int J Oral Maxillofac Surg 38: 201-209.
57. Nukavarapu S, Wallace J, Elgendy H, Lieberman J, Laurencin C, Hollinger J,. 2011. An introduction to biomaterials and their applications. Bone and biomaterials 2: 571-593.
58. Oh S, Oh N, Appleford M, Ong JL,. 2006. Bioceramics for tissue engineering applications-A review. Am J Biochem Biotechnol 2: 49.
59. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR,. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284 (5411): 143-147.
60. Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, Apostolou E, Stadtfeld M, Li Y, Shioda T, Natesan S, Wagers AJ, Melnick A, Evans T, Hochedlinger K,. 2010. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 28: 848-855.
61. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M,. 2001. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344: 385-386.
62. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR,. 2006. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27: 3413-3431.
63. Richards M, Tan S, Fong CY, Biswas A, Chan WK, Bongso A,. 2003. Comparative evaluation of various human feeders for prolonged undifferentiated growth of human embryonic stem cells. Stem Cells 21: 546-556.
64. Robey PG,. 2011. Cell sources for bone regeneration: The good, the bad, and the ugly (but promising). Tissue Eng Part B Rev 17: 423-430.
65. Rosland GV, Svendsen A, Torsvik A, Sobala E, McCormack E, Immervoll H, Mysliwietz J, Tonn JC, Goldbrunner R, Lonning PE, Bjerkvig R, Schichor C,. 2009. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 69: 5331-5339.
66. Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, Lloyd AC, Bernad A,. 2005. Spontaneous human adult stem cell transformation. Cancer Res 65: 3035-3039.
67. Shayesteh YS, Khojasteh A, Soleimani M, Alikhasi M, Khoshzaban A, Ahmadbeigi N,. 2008. Sinus augmentation using human mesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaffold. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106: 203-209.
68. Song I, Kim BS, Kim CS, Im GI,. 2011. Effects of BMP-2 and vitamin D3 on the osteogenic differentiation of adipose stem cells. Biochem Biophys Res Commun 408: 126-131.
69. Siddappa R, Martens A, Doorn J, Leusink A, Olivo C, Licht R, van Rijn L, Gaspar C, Fodde R, Janssen F, van Blitterswijk C, de Boer J,. 2008. CAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci U S A 105: 7281-7286.
70. Stres HK, Krkovič M, Koder J, Maličev E, Marolt D, Drobnic M, Kregar-Velikonja N,. 2007. Mesenchymal stem cells: A modern approach to treat long bones defects: "11th Mediterranean Conference on Medical and Biomedical Engineering and Computing 2007". Springer 253-256.
71. Suh KT, Kim SW, Roh HL, Youn MS, Jung JS,. 2005. Decreased osteogenic differentiation of mesenchymal stem cells in alcohol-induced osteonecrosis. Clin Orthop Relat Res 431: 220-225.
72. Takahashi K, Yamanaka S,. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
73. Tasso R, Pennesi G,. 2009. When stem cells meet immunoregulation. Int Immunopharmacol 9: 596-598.
74. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC,. 2003. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 75: 389-397.
75. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA,. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.